As the authors reported in Radiology Case Reports, the patient had no history of cancer and had no pain, weakness, numbness, or other spine-related symptoms. Lab tests confirmed she had severe anemia; ...

Bridge Institute of Experimental Tumour Therapy, West German Cancer Center, University Hospital Essen ... the mice that have a G-stage of at least 1 in our subsequent analyses. Immunohistochemistry ...

MET immunohistochemistry testing specifically assesses the overexpression of the MET protein, a key driver associated with poor prognosis in this cancer subtype. This level of molecular detail also ...

Fibroblasts play a central role in maintaining healthy tissue structures, as well as in the development and progression of ...

Adverse events (AEs), including treatment-related adverse events (TrAEs), were recorded at every visit from baseline throughout treatment and for 30 days after treatment discontinuation and graded ...